Observational cohort of patients treated with stereotactic radiotherapy for Oligo LYMPh nOde and other soft tissue metastasiS; the OLYMPOS cohort

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29672

Enrollment

700

Registered

2021-02-01

Start date

2017-12-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oligometastatic cancer

Interventions

stereotactic radiotherapy (SBRT) of soft tissue oligometastases

Eligibility

Inclusion criteria

Inclusion criteria: Patients are eligible when they meet the following criteria: • Is referred for, or will receive, stereotactic radiotherapy of a soft tissue metastasis with a localization other than brain or lung. • Informed consent – at least – for use of routinely collected clinical data for research purposes (including follow up data in other hospitals)

Exclusion criteria

Exclusion criteria: Patients are ineligible when they meet the following criteria: • Age <18 years • Mentally incompetent patients

Design outcomes

Primary

Measure	Time frame
progression free survival after SBRT	—

Secondary

Measure	Time frame
Physician-reported toxicity (CTCAE), overall survival, time until start of systemic treatment, patient-reported Quality of Life	—

Contacts

Public ContactAnita Werensteijn-Honingh

UMC Utrecht department of Radiotherapy

a.m.honingh@umcutrecht.nl+31887569277

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)